Cargando…

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418

Emerging evidence has indicated that abnormal microRNAs (miRNAs) participated in carcinogenesis and tumor progression in hepatocellular carcinoma (HCC). Better understanding the association between miRNAs and HCC may contribute to discover novel therapeutic approaches for diagnosis and treatments. I...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liang, Sun, Liankang, Wang, Yufeng, Yao, Bowen, Liu, Runkun, Chen, Tianxiang, Tu, Kangsheng, Liu, Qingguang, Liu, Zhikui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6643133/ https://www.ncbi.nlm.nih.gov/pubmed/31337980 http://dx.doi.org/10.7150/ijbs.33658

Ejemplares similares

miR-1204 promotes hepatocellular carcinoma progression through activating MAPK and c-Jun/AP1 signaling by targeting ZNF418 : Retraction
por: Wang, Liang, et al.
Publicado: (2022)

Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2019)

Retraction Note: Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2022)

MicroRNA-875-5p inhibits tumor growth and metastasis of hepatocellular carcinoma by targeting eukaryotic translation initiation factor 3 subunit a
por: Chen, Tianxiang, et al.
Publicado: (2020)

CXCR4 mediates matrix stiffness-induced downregulation of UBTD1 driving hepatocellular carcinoma progression via YAP signaling pathway
por: Yang, Nan, et al.
Publicado: (2020)

Resolvin D1 prevents epithelial-mesenchymal transition and reduces the stemness features of hepatocellular carcinoma by inhibiting paracrine of cancer-associated fibroblast-derived COMP
por: Sun, Liankang, et al.
Publicado: (2019)

LncRNA RUNX1-IT1 which is downregulated by hypoxia-driven histone deacetylase 3 represses proliferation and cancer stem-like properties in hepatocellular carcinoma cells
por: Sun, Liankang, et al.
Publicado: (2020)

Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2018)

Correction: Long non-coding RNA DSCR8 acts as a molecular sponge for miR-485-5p to activate Wnt/β-catenin signal pathway in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2022)

Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression
por: Wang, Liang, et al.
Publicado: (2021)

HIF-1α-activated long non-coding RNA KDM4A-AS1 promotes hepatocellular carcinoma progression via the miR-411-5p/KPNA2/AKT pathway
por: Chen, Tianxiang, et al.
Publicado: (2021)

Long noncoding RNA PICSAR/miR‐588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway
por: Liu, Zhikui, et al.
Publicado: (2020)

Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2018)

Hypoxia-induced up-regulation of VASP promotes invasiveness and metastasis of hepatocellular carcinoma: Erratum
por: Liu, Zhikui, et al.
Publicado: (2023)

ZNF521 which is downregulated by miR-802 suppresses malignant progression of Hepatocellular Carcinoma through regulating Runx2 expression
por: Yang, Nan, et al.
Publicado: (2020)

HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways
por: Li, Qing, et al.
Publicado: (2018)

MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2018)

Retraction Note: MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2022)

Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis
por: Wang, Yufeng, et al.
Publicado: (2017)

Hypoxia‐induced cofilin 1 promotes hepatocellular carcinoma progression by regulating the PLD1/AKT pathway
por: Yao, Bowen, et al.
Publicado: (2021)

Lymphocyte‐specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation
por: Zhang, Hongyong, et al.
Publicado: (2016)

BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
por: Yin, Guozhi, et al.
Publicado: (2016)

MiR-324-3p promotes tumor growth through targeting DACT1 and activation of Wnt/β-catenin pathway in hepatocellular carcinoma
por: Tuo, Hang, et al.
Publicado: (2017)

Retraction Note: BCORL1 is an independent prognostic marker and contributes to cell migration and invasion in human hepatocellular carcinoma
por: Yin, Guozhi, et al.
Publicado: (2023)

Correction to: Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2022)

Matrix stiffness modulates hepatic stellate cell activation into tumor-promoting myofibroblasts via E2F3-dependent signaling and regulates malignant progression
por: Liu, Zhikui, et al.
Publicado: (2021)

MicroRNA-212 suppresses tumor growth of human hepatocellular carcinoma by targeting FOXA1
por: Dou, Changwei, et al.
Publicado: (2015)

Ftx non coding RNA-derived miR-545 promotes cell proliferation by targeting RIG-I in hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2016)

Chromatin assembly factor 1, subunit A (P150) facilitates cell proliferation in human hepatocellular carcinoma
por: Xu, Meng, et al.
Publicado: (2016)

Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma
por: Liu, Zhikui, et al.
Publicado: (2016)

microRNA‐1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39‐mediated PI3K/AKT/mTOR pathway in HCC
por: Sun, Liankang, et al.
Publicado: (2019)

ZNF418 overexpression protects against gastric carcinoma and prompts a good prognosis
por: Hui, Hong-xia, et al.
Publicado: (2018)

Long non-coding RNA TUSC7 acts a molecular sponge for miR-10a and suppresses EMT in hepatocellular carcinoma
por: Wang, Yufeng, et al.
Publicado: (2016)

MicroRNA-519a promotes tumor growth by targeting PTEN/PI3K/AKT signaling in hepatocellular carcinoma
por: TU, KANGSHENG, et al.
Publicado: (2015)

Hypoxia-induced lncRNA MRVI1-AS1 accelerates hepatocellular carcinoma progression by recruiting RNA-binding protein CELF2 to stabilize SKA1 mRNA
por: Tuo, Hang, et al.
Publicado: (2023)

A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis
por: Wang, Yufeng, et al.
Publicado: (2019)

MiR-4319 induced an inhibition of epithelial-mesenchymal transition and prevented cancer stemness of HCC through targeting FOXQ1
por: Han, Shaoshan, et al.
Publicado: (2019)

Repression of the miR-627-5p by histone deacetylase 3 contributes to hypoxia-induced hepatocellular carcinoma progression
por: Wang, Jun, et al.
Publicado: (2021)

BCL-3 promotes the tumor growth of hepatocellular carcinoma by regulating cell proliferation and the cell cycle through cyclin D1
por: Tu, Kangsheng, et al.
Publicado: (2022)

MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway
por: Xu, Qiuran, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lhrnesr13qeo8k5o4g0gt3k0bc